Anemia long has been recognized as a major public health problem affecting about 10% of the population in developed countries and 25–50% in developing countries ⁽¹⁾. The most common type of anemia encountered is iron deficiency anemia and its distribution is worldwide. It is estimated that 30% of the global population suffers from IDA; most of those affected live in developing countries^(2,3)

Due to exclusive inclusion of milk in the first year of life, the amount of iron required is not met by dietary sources. The current study has been undertaken as a randomized, controlled clinical trial, to study the impact of delayed cord clamping in the newborn and infant in relation to both short come and long term outcomes.